News
VVOS
0.4983
+9.64%
0.0438
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 1d ago
Vivos Therapeutics says Vida oral appliance improves insomnia in study
TipRanks · 1d ago
Vivos Therapeutics Announces Its Treatment With ITS FDA-Cleared Vida Oral Appliance Demonstrates Enhancement In Insomnia Severity In 100% Of Patients In Trial
Benzinga · 2d ago
Vivos says study shows Vida oral appliance cuts insomnia severity in all 37 patients
PUBT · 2d ago
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
Barchart · 2d ago
Weekly Report: what happened at VVOS last week (0622-0626)?
Weekly Report · 3d ago
Vivos Therapeutics Extends Debt-for-Equity Conversion Timeline
TipRanks · 6d ago
Vivos Therapeutics extends Streeterville debt-to-equity conversion deal through Aug. 31, 2026
PUBT · 6d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/23 21:05
Vivos Extends Streeterville Financing Deal Through Aug. 31, Reaffirms Plan To Convert Up To $4.5M Debt Into Preferred And Common Stock
Benzinga · 06/22 12:40
Streeterville Extends Strategic Financing Deal With Streeterville Through August 31, Reaffirming Plan To Convert Up To $4.5M Debt Into Preferred And Common Stock
Benzinga · 06/22 12:35
Vivos Therapeutics extends Streeterville deal to convert up to $4.5 million debt into equity
PUBT · 06/22 12:30
VIVOS THERAPEUTICS - STREETERVILLE EXTENDS AGREEMENT TO AUG 31, 2026, REAFFIRMS $4.5 MLN DEBT CONVERSION COMMITMENT
Reuters · 06/22 12:30
Press Release: Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
Dow Jones · 06/22 12:30
Weekly Report: what happened at VVOS last week (0615-0619)?
Weekly Report · 06/22 09:00
Vivos Therapeutics Plans Rights Offering to Existing Shareholders
TipRanks · 06/16 22:26
Vivos Therapeutics plans registration statement for transferable shareholder rights offering
PUBT · 06/16 21:03
Vivos Therapeutics Forms AIM Florida Sleep Care Venture
TipRanks · 06/16 10:43
Vivos Therapeutics partners with South Palm Cardiovascular to launch Florida sleep apnea, insomnia services venture
PUBT · 06/16 10:02
Weekly Report: what happened at VVOS last week (0608-0612)?
Weekly Report · 06/15 09:00
More
Webull provides a variety of real-time VVOS stock news. You can receive the latest news about Vivos Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About VVOS
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.